Mobile website
Archive > Volume 28 Issue 4 > 2021,28(4):317-324. DOI:10.3872/j.issn.1007-385X.2021.04.001 Prev Next
Expert Forum
Current state and progression of advanced melanoma treatment under precision medicine
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
In the past, surgery and chemotherapy were the main treatment strategies for malignant melanoma, but companied with poor prognosis. With the development of high-throughput gene sequencing technology and the deepening understanding of tumor molecular mechanisms, it has been found that tumor heterogeneity and the diversity of tumor microenvironment affect tumor formation,drug resistance and treatment selection, leading to different responses and benefits of melanoma patients to the same treatment. The emerge and progression of targeted therapy and immunotherapy have significantly increased the survival rates of patients with metastatic melanoma, promoting the individualization and precision of melanoma treatment and making precise treatment a research hotspot as well as a trend. This review mainly summarizes the research progress of systemic individualized treatment of advanced melanoma based on precise subtyping and molecular level, and to get a more comprehensive view of the survival status of melanoma patients in the era of precision medicine, as well as the prospect and necessity of developing various targeted therapy, immunotherapy or combination therapy.
Keywords:
Project Supported:
Project supported by the National Natural Science Foundation of China (No. 81972566), the Peking University Clinical Medicine Plus X-Young Scholars Project (No. PKU2019LCXQ017), the Bethune Charitable Foundation (No. BQE-TY-SSPC[1]-N-05), and the Beijing Medical Award Foundation (No. YXJL-2020-0889-0106)
Clc Number:
